NDSIB
MRNA icon

North Dakota State Investment Board’s Moderna MRNA Stock Holding History

North Dakota State Investment Board’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.02M Buy
43,152
+32,677
+312% +$1.69M 0.12% 126
2026
Q1 		$532K Sell
10,475
-1,697
-14% -$79.2K 0.02% 451
2025
Q4 		$359K Buy
+12,172
New +$331K 0.01% 628

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

North Dakota State Investment Board's MRNA Position: Q2 2026 in Review

North Dakota State Investment Board increased its Moderna (MRNA) stake by 312% in Q2 2026, buying an estimated $1.69M and bringing the position to 43,152 shares worth $3.02M. The position accounts for 0.12% of the portfolio, ranked #126.

North Dakota State Investment Board first reported a position in MRNA in Q4 2025 and has held it in 3 quarters since. 775 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • North Dakota State Investment Board held 43,152 shares of Moderna worth $3.02M as of Q2 2026.
  • North Dakota State Investment Board bought 32,677 Moderna shares in Q2 2026, an estimated $1.69M.
  • Moderna made up 0.12% of North Dakota State Investment Board's portfolio in Q2 2026, its #126 holding.
  • North Dakota State Investment Board first reported a position in Moderna in Q4 2025 and has held it in 3 quarters since.
  • 775 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on North Dakota State Investment Board's 13F filing for Q2 2026, filed 4 Aug 2026.